MedTrace Logo

HFpEF and Symptomatic Obstructive Iliofemoral Venous Disease Study

NCT04964817 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2023-04-18

No results posted yet for this study

Summary

To ascertain the potential symptom improvement assessed by Cardiopulmonary Exercise Testing (CPET) in subjects with heart failure with preserved ejection fraction (HFpEF) and nonthrombotic iliofemoral venous lesions and/or iliocaval obstruction defined by MR or CT venography AND CEAP Clinical Category ≥3 prior to venous stenting.

Conditions

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Medtronic

    collaborator INDUSTRY

  • Philips Healthcare

    collaborator INDUSTRY

  • Prairie Education and Research Cooperative

    lead INDUSTRY

Principal Investigators

  • Krishna Rocha-Singh, MD · Prairie Cardiovascular Consultants

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-03
Primary Completion
2023-04-12
Completion
2023-04-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04964817 on ClinicalTrials.gov